https://www.selleckchem.com/pr....oducts/2-6-dihydroxy
8%) or satisfied (28.1%) with PR-T at the final visit. Among patients reporting a preference, 78.4% preferred PR-T, 2.2% preferred IR-T, and 19.4% reported no preference. The safety profile of PR-T was consistent with that previously described. Conversion of stable kidney transplant recipients from IR-T to PR-T provided stable kidney and graft function over 12 months (Verband Forschender Arzneimittelhersteller--registered study NIS ADV-02). Conversion of stable kidney transplant recipients from IR-T to PR-T provided stable k
Like
Comment
Share
